Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GD-11 for injection in acute ischemic stroke
CTR20240274Phase 3Completed
- Sponsor
- Jiangsu Wengao Pharmaceutical
- Start
- Jan 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of GD-11 in ischemic stroke, sponsored by Jiangsu Wengao Pharmaceutical. Started Jan 2024; status: completed.
02
Drugs
GD-11
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on CTR20240274.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20240274.